- Federal agenciesImproved federal coordination could accelerate research translation and reduce duplicative efforts across agencies.
- Potential benefitIdentifying knowledge gaps may guide targeted funding toward lung cancer research in women and underserved populations.
- Potential benefitRecommendations could lead to expanded screening strategies, increasing early detection among eligible women and unders…
Women and Lung Cancer Research and Preventive Services Act of 2025
Ordered to be Reported by Voice Vote.
The bill directs the Secretary of Health and Human Services, with the Departments of Defense and Veterans Affairs, to conduct an interagency review evaluating the status of research on lung cancer in women and underserved populations, access to preventive services, and public awareness efforts. The review must identify research gaps, collaborative opportunities (including environmental and genomic studies and imaging advances), options for a national screening strategy, and public education opportunities.
Liberals emphasize addressing disparities and funding follow-up
Relative to its intended legislative type, this bill is a clearly scoped statutory mandate for an interagency review and report on lung cancer research and preventive services for women and underserved populations.
The bill directs the Secretary of Health and Human Services, with the Departments of Defense and Veterans Affairs, to conduct an interagency review evaluating the status of research on lung cancer in women and underserved populations, access to preventive services, and public awareness efforts.
The review must identify research gaps, collaborative opportunities (including environmental and genomic studies and imaging advances), options for a national screening strategy, and public education opportunities.
A report with findings and recommendations must be submitted to Congress within two years of enactment.
Simple, noncontroversial reporting bill with limited fiscal impact has a solid chance of enactment, though lack of funding authorization could reduce urgency.
Relative to its intended legislative type, this bill is a clearly scoped statutory mandate for an interagency review and report on lung cancer research and preventive services for women and underserved populations. It specifies lead and consulting entities, enumerates substantive topics to be addressed, and sets a two-year reporting deadline, but it omits funding, detailed procedural mechanics, and mechanisms for follow-up or measurement beyond the single report.
Liberals emphasize addressing disparities and funding follow-up
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe mandated review imposes administrative costs and workload on HHS, DOD, and VA without funding authorization.
- Potential burdenA two-year timeline delays actionable policy changes and immediate improvements in screening access.
- Federal agenciesRecommendations may require new federal spending or impose implementation costs on states and health systems.
Why the argument around this bill splits.
Liberals emphasize addressing disparities and funding follow-up
Likely broadly supportive because the bill targets health disparities, women's health, and underserved populations.
It advances research priorities, screening access, and national awareness—areas aligned with public-health equity goals.
Would view the report as a first step but may push for concrete funding and policy followups.
Generally favorable as a modest, evidence-seeking measure that promotes coordination and fills knowledge gaps.
Values the interagency approach and the report requirement, while wanting clear cost estimates and measurable next steps.
May press for accountability and an assessment of benefits versus costs.
Mixed to somewhat skeptical: support for research and early detection exists, but concerns center on federal scope, cost, and potential for mandates.
Because the bill only requires a review and report, many conservatives may tolerate it but will watch for any push toward expanded federal programs or mandates.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Simple, noncontroversial reporting bill with limited fiscal impact has a solid chance of enactment, though lack of funding authorization could reduce urgency.
- No explicit funding authorization for the review
- Interagency coordination effectiveness and timelines
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize addressing disparities and funding follow-up
Simple, noncontroversial reporting bill with limited fiscal impact has a solid chance of enactment, though lack of funding authorization co…
Relative to its intended legislative type, this bill is a clearly scoped statutory mandate for an interagency review and report on lung cancer research and preventive services for women and underserved populations. It s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.